Annual CFF
$56.18 M
+$57.41 M+4633.98%
December 31, 2023
Summary
- As of February 6, 2025, CTNM annual cash flow from financing activities is $56.18 million, with the most recent change of +$57.41 million (+4633.98%) on December 31, 2023.
- During the last 3 years, CTNM annual CFF has fallen by -$23.66 million (-29.64%).
- CTNM annual CFF is now -29.64% below its all-time high of $79.84 million, reached on December 1, 2021.
Performance
CTNM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$13.00 K
-$108.35 M-99.99%
September 30, 2024
Summary
- As of February 6, 2025, CTNM quarterly cash flow from financing activities is $13.00 thousand, with the most recent change of -$108.35 million (-99.99%) on September 30, 2024.
- Over the past year, CTNM quarterly CFF has increased by +$334.00 thousand (+104.05%).
- CTNM quarterly CFF is now -99.99% below its all-time high of $108.36 million, reached on June 30, 2024.
Performance
CTNM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$108.04 M
-$10.31 M-8.71%
September 30, 2024
Summary
- As of February 6, 2025, CTNM TTM cash flow from financing activities is $108.04 million, with the most recent change of -$10.31 million (-8.71%) on September 30, 2024.
- Over the past year, CTNM TTM CFF has increased by +$51.86 million (+92.32%).
- CTNM TTM CFF is now -8.71% below its all-time high of $118.35 million, reached on June 30, 2024.
Performance
CTNM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CTNM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4634.0% | +104.0% | +92.3% |
| 3 y3 years | -29.6% | - | - |
| 5 y5 years | -29.6% | - | - |
CTNM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | +4634.0% | -100.0% | +102.1% | -8.7% | >+9999.0% |
| 5 y | 5-year | -29.6% | +4634.0% | -100.0% | +102.1% | -8.7% | >+9999.0% |
| alltime | all time | -29.6% | +4634.0% | -100.0% | +102.1% | -8.7% | >+9999.0% |
Contineum Therapeutics Class A Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.00 K(-100.0%) | $108.04 M(-8.7%) |
| Jun 2024 | - | $108.36 M(<-9900.0%) | $118.35 M(+108.5%) |
| Mar 2024 | - | -$18.00 K(-94.4%) | $56.77 M(+1.1%) |
| Dec 2023 | $56.18 M | -$321.00 K(-103.1%) | $56.18 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $10.32 M(-77.9%) | $56.50 M(+22.4%) |
| Jun 2023 | - | $46.79 M(-7683.3%) | $46.17 M(-7583.3%) |
| Mar 2023 | - | -$617.00 K | -$617.00 K |
| Dec 2022 | -$1.24 M(-101.6%) | - | - |
| Dec 2021 | $79.84 M | - | - |
FAQ
- What is Contineum Therapeutics Class A annual cash flow from financing activities?
- What is the all time high annual CFF for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual CFF year-on-year change?
- What is Contineum Therapeutics Class A quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly CFF year-on-year change?
- What is Contineum Therapeutics Class A TTM cash flow from financing activities?
- What is the all time high TTM CFF for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A TTM CFF year-on-year change?
What is Contineum Therapeutics Class A annual cash flow from financing activities?
The current annual CFF of CTNM is $56.18 M
What is the all time high annual CFF for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual cash flow from financing activities is $79.84 M
What is Contineum Therapeutics Class A annual CFF year-on-year change?
Over the past year, CTNM annual cash flow from financing activities has changed by +$57.41 M (+4633.98%)
What is Contineum Therapeutics Class A quarterly cash flow from financing activities?
The current quarterly CFF of CTNM is $13.00 K
What is the all time high quarterly CFF for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly cash flow from financing activities is $108.36 M
What is Contineum Therapeutics Class A quarterly CFF year-on-year change?
Over the past year, CTNM quarterly cash flow from financing activities has changed by +$334.00 K (+104.05%)
What is Contineum Therapeutics Class A TTM cash flow from financing activities?
The current TTM CFF of CTNM is $108.04 M
What is the all time high TTM CFF for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high TTM cash flow from financing activities is $118.35 M
What is Contineum Therapeutics Class A TTM CFF year-on-year change?
Over the past year, CTNM TTM cash flow from financing activities has changed by +$51.86 M (+92.32%)